Related Experiment Video
Updated: Jun 24, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Varicella zoster virus redux
1Washington University School of Medicine, St Louis, MO 63110, USA. ldgelb@swbell.net
Abstract:
In May 2008, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention in the USA recommended the routine administration of a live-attenuated high-potency varicella zoster vaccine to all adults over 60 years of age without specific contraindications, for the prevention and attenuation of herpes zoster (HZ). Nevertheless, many physicians still consider this vaccine to be of marginal value. This is not a reasonable conclusion. This short article reviews available data.
Related Concept Videos
Chickenpox
Smallpox
Viral Recombination
Vaccinations
Respiratory Syncytial Virus Disease
Cytomegalovirus Disease

